|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Company’s product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.
- Str. Logofatul Tautu nr. 99, Sector 3, BUCURESTI, 031212
- +40 213010600
- Daniel Constantin
- BDO Audit SRL
As of Today at 13:03 UTC, shares in Biofarm SA are trading at RON0.58. This share price information is delayed by 15 minutes.
Shares in Biofarm SA last closed at RON0.58 and the price had moved by -7.1% over the past 365 days. In terms of relative price strength the Biofarm SA share price has outperformed the FTSE Global All Cap Index by +2.58% over the past year.
There is no consensus recommendation for this security.
The Biofarm SA dividend yield is 4.17% based on the trailing twelve month period.
Last year, Biofarm SA paid a total dividend of RON0.02, and it currently has a trailing dividend yield of 4.17%. We do not have any data on when Biofarm SA is to next pay dividends.
We do not have data on when Biofarm SA is to next pay dividends. The historic dividend yield on Biofarm SA shares is currently 4.17%.
To buy shares in Biofarm SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of RON0.58, shares in Biofarm SA had a market capitalisation of RON567.57m.
Here are the trading details for Biofarm SA:
- Country of listing: Romania
- Exchange: BUH
- Ticker Symbol: BIO
Based on an overall assessment of its quality, value and momentum Biofarm SA is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biofarm SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -6.94%.
As of the last closing price of RON0.58, shares in Biofarm SA were trading -14.43% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Biofarm SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at RON0.58.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Biofarm SA's management team is headed by:
- Andrei Hrebenciuc - CHM
- Catalin Vicol - CEO
- Monica Matei - CAO
- Liviu Visan - CAD
- Zoia Ion - GCN
- Oana Gherla - DHR
- Petruta Stoicescu - OTH
- Nicusor - Marian Buica - DRC
- Bogdan Dragoi - NED